Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer.
This report elaborates on the current development of the Cancer Hormone Therapy Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
By Type:
Antiandrogens
Tamoxifen
Other
Aromatase Inhibitors
Androgen Synthesis Inhibitors
By Application:
Breast Cancer
Prostate Cancer
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Cancer Hormone Therapy Drugs Market Overview 2018-2029
-
1.1 China Cancer Hormone Therapy Drugs Industry Development Overview
-
1.2 China Cancer Hormone Therapy Drugs Industry Development History
-
1.3 China Cancer Hormone Therapy Drugs Industry Market Size (2018-2029)
-
1.4 China Cancer Hormone Therapy Drugs Market Analysis by Type from Production Side
-
1.4.1 China Cancer Hormone Therapy Drugs Production Volume, Production Value and Growth Rate of Antiandrogens (2018-2029)
-
1.4.2 China Cancer Hormone Therapy Drugs Production Volume, Production Value and Growth Rate of Tamoxifen (2018-2029)
-
1.4.3 China Cancer Hormone Therapy Drugs Production Volume, Production Value and Growth Rate of Other (2018-2029)
-
1.4.4 China Cancer Hormone Therapy Drugs Production Volume, Production Value and Growth Rate of Aromatase Inhibitors (2018-2029)
-
1.4.5 China Cancer Hormone Therapy Drugs Production Volume, Production Value and Growth Rate of Androgen Synthesis Inhibitors (2018-2029)
-
1.5 China Cancer Hormone Therapy Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Cancer Hormone Therapy Drugs Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)
-
1.5.2 China Cancer Hormone Therapy Drugs Sales Volume, Sales Value and Growth Rate of Prostate Cancer (2018-2029)
-
1.6 China Cancer Hormone Therapy Drugs Market Analysis by Region
-
1.6.1 North China Cancer Hormone Therapy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Cancer Hormone Therapy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Cancer Hormone Therapy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Cancer Hormone Therapy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Cancer Hormone Therapy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Cancer Hormone Therapy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Cancer Hormone Therapy Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Cancer Hormone Therapy Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Cancer Hormone Therapy Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Cancer Hormone Therapy Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Cancer Hormone Therapy Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Cancer Hormone Therapy Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Cancer Hormone Therapy Drugs Industry Development
Chapter 3 Cancer Hormone Therapy DrugsIndustry Chain Analysis
-
3.1 Cancer Hormone Therapy Drugs Industry Chain
-
3.2 Cancer Hormone Therapy Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Cancer Hormone Therapy Drugs Market
-
3.3 Cancer Hormone Therapy Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Cancer Hormone Therapy Drugs Market
Chapter 4 China Cancer Hormone Therapy Drugs Market, by Type
-
4.1 China Cancer Hormone Therapy Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Cancer Hormone Therapy Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Cancer Hormone Therapy Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Cancer Hormone Therapy Drugs Production Volume and Growth Rate of Antiandrogens
-
4.5.2 China Cancer Hormone Therapy Drugs Production Volume and Growth Rate of Tamoxifen
-
4.5.3 China Cancer Hormone Therapy Drugs Production Volume and Growth Rate of Other
-
4.5.4 China Cancer Hormone Therapy Drugs Production Volume and Growth Rate of Aromatase Inhibitors
-
4.5.5 China Cancer Hormone Therapy Drugs Production Volume and Growth Rate of Androgen Synthesis Inhibitors
Chapter 5 China Cancer Hormone Therapy Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Cancer Hormone Therapy Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Cancer Hormone Therapy Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Cancer Hormone Therapy Drugs Market Size and Growth Rate of Breast Cancer
-
5.5.2 China Cancer Hormone Therapy Drugs Market Size and Growth Rate of Prostate Cancer
Chapter 6 China Cancer Hormone Therapy Drugs Market, by Region
-
6.1 China Cancer Hormone Therapy Drugs Production Volume and Production Value, by Region
-
6.2 China Cancer Hormone Therapy Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Cancer Hormone Therapy Drugs Market Analysis
-
7.1 North China Cancer Hormone Therapy Drugs Market, by Type
-
7.2 North China Cancer Hormone Therapy Drugs Market, by Application
Chapter 8 Central China Cancer Hormone Therapy Drugs Market Analysis
-
8.1 Central China Cancer Hormone Therapy Drugs Market, by Type
-
8.2 Central China Cancer Hormone Therapy Drugs Market, by Application
Chapter 9 South China Cancer Hormone Therapy Drugs Market Analysis
-
9.1 South China Cancer Hormone Therapy Drugs Market, by Type
-
9.2 South China Cancer Hormone Therapy Drugs Market, by Application
Chapter 10 East China Cancer Hormone Therapy Drugs Market Analysis
-
10.1 East China Cancer Hormone Therapy Drugs Market, by Type
-
10.2 East China Cancer Hormone Therapy Drugs Market, by Application
Chapter 11 Northeast China Cancer Hormone Therapy Drugs Market Analysis
-
11.1 Northeast China Cancer Hormone Therapy Drugs Market, by Type
-
11.2 Northeast China Cancer Hormone Therapy Drugs Market, by Application
Chapter 12 Southwest China Cancer Hormone Therapy Drugs Market Analysis
-
12.1 Southwest China Cancer Hormone Therapy Drugs Market, by Type
-
12.2 Southwest China Cancer Hormone Therapy Drugs Market, by Application
Chapter 13 Northwest China Cancer Hormone Therapy Drugs Market Analysis
-
13.1 Northwest China Cancer Hormone Therapy Drugs Market, by Type
-
13.2 Northwest China Cancer Hormone Therapy Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 Company 1
-
14.1.1 Company 1 Company Profile
-
14.1.2 Company 1 Cancer Hormone Therapy Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Company 2
-
14.2.1 Company 2 Company Profile
-
14.2.2 Company 2 Cancer Hormone Therapy Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Company 3
-
14.3.1 Company 3 Company Profile
-
14.3.2 Company 3 Cancer Hormone Therapy Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Company 4
-
14.4.1 Company 4 Company Profile
-
14.4.2 Company 4 Cancer Hormone Therapy Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Company 5
-
14.5.1 Company 5 Company Profile
-
14.5.2 Company 5 Cancer Hormone Therapy Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Company 6
-
14.6.1 Company 6 Company Profile
-
14.6.2 Company 6 Cancer Hormone Therapy Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Company 7
-
14.7.1 Company 7 Company Profile
-
14.7.2 Company 7 Cancer Hormone Therapy Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Company 8
-
14.8.1 Company 8 Company Profile
-
14.8.2 Company 8 Cancer Hormone Therapy Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Company 9
-
14.9.1 Company 9 Company Profile
-
14.9.2 Company 9 Cancer Hormone Therapy Drugs Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Company 10
-
14.10.1 Company 10 Company Profile
-
14.10.2 Company 10 Cancer Hormone Therapy Drugs Market Performance
-
14.10.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Cancer Hormone Therapy Drugs Industry Research Conclusions
-
15.2 Cancer Hormone Therapy Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Cancer Hormone Therapy Drugs Industry Market Size (2018-2029)
-
Figure China Cancer Hormone Therapy Drugs Production Volume, Production Value and Growth Rate of Antiandrogens (2018-2029)
-
Figure China Cancer Hormone Therapy Drugs Production Volume, Production Value and Growth Rate of Tamoxifen (2018-2029)
-
Figure China Cancer Hormone Therapy Drugs Production Volume, Production Value and Growth Rate of Other (2018-2029)
-
Figure China Cancer Hormone Therapy Drugs Production Volume, Production Value and Growth Rate of Aromatase Inhibitors (2018-2029)
-
Figure China Cancer Hormone Therapy Drugs Production Volume, Production Value and Growth Rate of Androgen Synthesis Inhibitors (2018-2029)
-
Figure China Cancer Hormone Therapy Drugs Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)
-
Figure China Cancer Hormone Therapy Drugs Sales Volume, Sales Value and Growth Rate of Prostate Cancer (2018-2029)
-
Figure North China Cancer Hormone Therapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Cancer Hormone Therapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Cancer Hormone Therapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Cancer Hormone Therapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Cancer Hormone Therapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Cancer Hormone Therapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Cancer Hormone Therapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Cancer Hormone Therapy Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Cancer Hormone Therapy Drugs Market Share by Type in 2018
-
Figure China Cancer Hormone Therapy Drugs Market Share by Type in 2023
-
Figure China Cancer Hormone Therapy Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Cancer Hormone Therapy Drugs Production Volume and Growth Rate of Antiandrogens (2018-2023)
-
Figure China Cancer Hormone Therapy Drugs Production Volume and Growth Rate of Tamoxifen (2018-2023)
-
Figure China Cancer Hormone Therapy Drugs Production Volume and Growth Rate of Other (2018-2023)
-
Figure China Cancer Hormone Therapy Drugs Production Volume and Growth Rate of Aromatase Inhibitors (2018-2023)
-
Figure China Cancer Hormone Therapy Drugs Production Volume and Growth Rate of Androgen Synthesis Inhibitors (2018-2023)
-
Figure China Cancer Hormone Therapy Drugs Market Share by Application in 2018
-
Figure China Cancer Hormone Therapy Drugs Market Share by Application in 2023
-
Figure China Cancer Hormone Therapy Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Cancer Hormone Therapy Drugs Market Size and Growth Rate of Breast Cancer (2018-2023)
-
Figure China Cancer Hormone Therapy Drugs Market Size and Growth Rate of Prostate Cancer (2018-2023)
-
Table China Cancer Hormone Therapy Drugs Production Volume by Region (2018-2023)
-
Table China Cancer Hormone Therapy Drugs Production Volume Share by Region (2018-2023)
-
Figure China Cancer Hormone Therapy Drugs Production Volume Share by Region (2018-2023)
-
Table China Cancer Hormone Therapy Drugs Production Value by Region (2018-2023)
-
Table China Cancer Hormone Therapy Drugs Production Value Share by Region (2018-2023)
-
Figure China Cancer Hormone Therapy Drugs Production Value Share by Region (2018-2023)
-
Table China Cancer Hormone Therapy Drugs Sales Volume by Region (2018-2023)
-
Table China Cancer Hormone Therapy Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Cancer Hormone Therapy Drugs Sales Volume Share by Region (2018-2023)
-
Table China Cancer Hormone Therapy Drugs Sales Value by Region (2018-2023)
-
Table China Cancer Hormone Therapy Drugs Sales Value Share by Region (2018-2023)
-
Figure China Cancer Hormone Therapy Drugs Sales Value Share by Region (2018-2023)
-
Table North China Cancer Hormone Therapy Drugs Production Volume by Type (2018-2023)
-
Table North China Cancer Hormone Therapy Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Cancer Hormone Therapy Drugs Production Volume Share by Type (2018-2023)
-
Table North China Cancer Hormone Therapy Drugs Sales Volume by Application (2018-2023)
-
Table North China Cancer Hormone Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Cancer Hormone Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Cancer Hormone Therapy Drugs Production Volume by Type (2018-2023)
-
Table Central China Cancer Hormone Therapy Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Cancer Hormone Therapy Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Cancer Hormone Therapy Drugs Sales Volume by Application (2018-2023)
-
Table Central China Cancer Hormone Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Cancer Hormone Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Cancer Hormone Therapy Drugs Production Volume by Type (2018-2023)
-
Table South China Cancer Hormone Therapy Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Cancer Hormone Therapy Drugs Production Volume Share by Type (2018-2023)
-
Table South China Cancer Hormone Therapy Drugs Sales Volume by Application (2018-2023)
-
Table South China Cancer Hormone Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Cancer Hormone Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Cancer Hormone Therapy Drugs Production Volume by Type (2018-2023)
-
Table East China Cancer Hormone Therapy Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Cancer Hormone Therapy Drugs Production Volume Share by Type (2018-2023)
-
Table East China Cancer Hormone Therapy Drugs Sales Volume by Application (2018-2023)
-
Table East China Cancer Hormone Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Cancer Hormone Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Cancer Hormone Therapy Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Cancer Hormone Therapy Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Cancer Hormone Therapy Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Cancer Hormone Therapy Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Cancer Hormone Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Cancer Hormone Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Cancer Hormone Therapy Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Cancer Hormone Therapy Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Cancer Hormone Therapy Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Cancer Hormone Therapy Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Cancer Hormone Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Cancer Hormone Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Cancer Hormone Therapy Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Cancer Hormone Therapy Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Cancer Hormone Therapy Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Cancer Hormone Therapy Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Cancer Hormone Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Cancer Hormone Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Table Company 1 Company Profile
-
Table Company 1 Cancer Hormone Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Company 2 Company Profile
-
Table Company 2 Cancer Hormone Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Company 3 Company Profile
-
Table Company 3 Cancer Hormone Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Company 4 Company Profile
-
Table Company 4 Cancer Hormone Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Company 5 Company Profile
-
Table Company 5 Cancer Hormone Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Company 6 Company Profile
-
Table Company 6 Cancer Hormone Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Company 7 Company Profile
-
Table Company 7 Cancer Hormone Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Company 8 Company Profile
-
Table Company 8 Cancer Hormone Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Company 9 Company Profile
-
Table Company 9 Cancer Hormone Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Company 10 Company Profile
-
Table Company 10 Cancer Hormone Therapy Drugs Revenue, Price and Gross (2018-2023)
-
